Table 1.
Patient characteristics (N=41).
| Variable | Results | |||
| Patient characteristics | ||||
|
|
Sex (male), n (%) | 25 (58) | ||
|
|
Age (years), median (IQR) | 68 (60-73) | ||
|
|
BMI, mean (SD) | 26.1 (4.2) | ||
|
|
Smoke status, n (%) | |||
|
|
|
Current | 5 (12) | |
|
|
|
Past | 24 (59) | |
|
|
|
Never | 12 (29) | |
|
|
Primary diagnosis, n (%) | |||
|
|
|
Rectum cancer | 1 (2) | |
|
|
|
Lung cancer | 21 (51) | |
|
|
|
Esophagus cancer | 8 (20) | |
|
|
|
Peritonitis carcinomatosa | 8 (20) | |
|
|
|
Schwannoma | 2 (5) | |
|
|
|
Thymoma | 1 (2) | |
|
|
Tumor stage, n (%) | |||
|
|
|
1 | 7 (17) | |
|
|
|
2 | 8 (20) | |
|
|
|
3 | 6 (15) | |
|
|
|
4 | 18 (44) | |
|
|
|
Schwannoma | 2 (5) | |
|
|
Comorbidities (ASAa score), n (%) | |||
|
|
|
Grade I | 3 (7) | |
|
|
|
Grade II | 27 (66) | |
|
|
|
Grade III | 10 (24) | |
|
|
|
Grade IV | 1 (2) | |
|
|
Type of treatment before surgery, n (%) | |||
|
|
|
Neoadjuvant chemotherapy | 3 (7) | |
|
|
|
Neoadjuvant chemoradiotherapy | 9 (22) | |
|
|
|
Neoadjuvant immunotherapy | 1 (2) | |
|
|
|
Neoadjuvant hormone therapy | 1 (2) | |
|
|
Sports ≥1 time per week, n (%) | 15 (37) | ||
|
|
|
Missing | 1 (2) | |
| Perioperative characteristics | ||||
|
|
Type of surgery, n (%) | |||
|
|
|
Lobectomy | 23 (56) | |
|
|
|
Esophagus resection | 7 (17) | |
|
|
|
HIPECb procedure | 10 (24) | |
|
|
|
Schwannoma resection | 1 (2) | |
|
|
Surgical approach, n (%) | |||
|
|
|
Video-assisted thoracic surgery | 6 (15) | |
|
|
|
Open surgery | 35 (85) | |
|
|
Type of treatment after surgery, n (%) | |||
|
|
|
Adjuvant chemoradiotherapy | 2 (5) | |
|
|
|
Adjuvant chemotherapy | 3 (7) | |
|
|
|
Adjuvant radiotherapy | 1 (2) | |
|
|
|
Adjuvant hormonotherapy | 1 (2) | |
|
|
Length of stay (days), median (IQR) | 7 (6-11) | ||
|
|
Complications (Clavien Dindo score), n (%) | |||
|
|
|
Grade I | 26 (63) | |
|
|
|
Grade II | 5 (12) | |
|
|
|
Grade IIIa | 2 (5) | |
|
|
|
Grade IIIb | 5 (12) | |
|
|
|
Grade IVa | 3 (7) | |
|
|
Hospital readmission, n (%) | 5 (12) | ||
|
|
Duration of operation (minutes), median (IQR) | 200 (128-336) | ||
aASA: American Society of Anesthesiologists.
bHIPEC: hyperthermic intraperitoneal chemotherapy.